Study of oral MG001 in healthy adults with recent opioid use
Part of Mental health clinical trials.
This trial tests an oral medication called MG001 in healthy adults who have used oral opioids recently, to see how safe it is. It may help researchers understand if this new treatment could one day help with opioid-related conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have used opioid pills (like prescription painkillers or other oral opioids) at least once in the last 30 days.
- You are generally healthy, without serious medical or psychiatric conditions.
- You have not used opioids by injection or for more than 2 days in a row in the last 30 days.
- If you are a woman, you cannot become pregnant (for example, have had surgery or gone through menopause).
- You must be willing to follow the study rules and use effective birth control if you are a man.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new medication (VK4-116) affects the body, especially when taken with or without food. It's looking for healthy volunteers to help understand the medication's safety and how it is processed.
This early-stage safety trial tests a new experimental medication called MCAM in healthy volunteers. Researchers will measure how well the body tolerates the drug and how it moves through your system, to ensure it's safe before later testing in patients.
This trial tests how safe certain psychoactive substances are and what effects they have in people who have used opioids in the past but are not currently dependent on them. It aims to gather information that could help future treatment options.
This early study tests how kratom can change the body’s handling of oxycodone (a prescription opioid) and how safe and measurable the effects are. It may help researchers understand drug interactions, especially for people who have used kratom and opioids before.
This early-stage study tests a new approach for opioid use disorder in adults. It aims to understand safety and how the treatment may work in people with opioid addiction.
This study tests a new medicine (ENA-001) that helps restore normal breathing when it has slowed down too much due to opioid painkillers. Healthy volunteers will receive the drug to see how safe it is and how the body handles it.
Hear when a new Safety and Tolerability in Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.